Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group

Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact

(2021) Uta Oelschlaegel et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet

(2021) Vincent H. J. Velden et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry

(2021) Orianne Wagner‐Ballon et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow Cytometry Working Group

(2021) Arjan A. Loosdrecht et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes

(2018) Carolien Duetz et al.   PATHOBIOLOGY

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias

(2016) Eline M.P. Cremers et al.   EUROPEAN JOURNAL OF CANCER

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes

(2016) Eline M.P. Cremers et al.   HAEMATOLOGICA

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

(2016) Theresia M. Westers et al.   HAEMATOLOGICA

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes

(2016) Eline M.P. Cremers et al.   HAEMATOLOGICA

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

(2016) Theresia M. Westers et al.   HAEMATOLOGICA

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

(2015) D. P. Steensma et al.   BLOOD

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

(2015) V. Bardet et al.   HAEMATOLOGICA

The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

(2015) C Alhan et al.   LEUKEMIA

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

(2015) V. Bardet et al.   HAEMATOLOGICA

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

(2014) A Porwit et al.   LEUKEMIA

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

(2013) L. Malcovati et al.   BLOOD

Clinical and biological implications of driver mutations in myelodysplastic syndromes

(2013) E. Papaemmanuil et al.   BLOOD

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

(2013) T Haferlach et al.   LEUKEMIA

Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics

(2012) W. Kern et al.   HAEMATOLOGICA

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

(2012) M. G. Della Porta et al.   HAEMATOLOGICA

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

(2012) T M Westers et al.   LEUKEMIA

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome

(2010) Wolfgang Kern et al.   CANCER

The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes

(2009) Ulrike Bacher et al.   CANCER

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study

(2009) K. Ogata et al.   HAEMATOLOGICA

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

(2009) A. A. van de Loosdrecht et al.   HAEMATOLOGICA

The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: A prospective study

(2009) Francoise Truong et al.   LEUKEMIA RESEARCH

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

(2008) B. L. Scott et al.   BLOOD

Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes

(2008) Chikako Satoh et al.   LEUKEMIA RESEARCH